Information:
Error:
ID
19369
Description
Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00088491
Link
https://clinicaltrials.gov/show/NCT00088491
Keywords
Versions (1)
- 12/22/16 12/22/16 -
Uploaded on
December 22, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Schizophrenic Disorders NCT00088491
Eligibility Schizophrenic Disorders NCT00088491
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenic Disorders NCT00088491
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Schizophrenia
Item
patients must have schizophrenia
boolean
C0036341 (UMLS CUI [1])
Antipsychotic Agents Clinical Stable
Item
patients must be clinically stable on antipsychotic medication
boolean
C0040615 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0205210 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Schizophrenia Symptoms Stable
Item
patients must be retrospectively judged by investigators, based on clinical interview and impression, to have been stable (with respect to their symptoms of schizophrenia) for at least 4 weeks entry into the study
boolean
C0036341 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Outpatients | Brief Psychiatric Rating Scale
Item
patients must be an outpatient and have bprs positive items scores of 4 or less to enter the study
boolean
C0029921 (UMLS CUI [1])
C0029941 (UMLS CUI [2])
C0029941 (UMLS CUI [2])
Childbearing Potential Contraceptive methods
Item
female patients of childbearing potential must be using a medically accepted means of contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,2])
Study Subject Participation Status | Investigational New Drugs | olanzapine
Item
patients must not have participated in a clinical trial of another investigational drug, including olanzapine, within 1 month (30 days) prior to study entry.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0171023 (UMLS CUI [3])
C0013230 (UMLS CUI [2])
C0171023 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
female patients must not be pregnant or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Medical condition acute | Medical condition Serious | Medical condition Unstable | Schizophrenia
Item
patients must not be experiencing acute, serious, or unstable medical conditions other than schizophrenia
boolean
C3843040 (UMLS CUI [1,1])
C0205178 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C3843040 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
C0036341 (UMLS CUI [4])
C0205178 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C3843040 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
C0036341 (UMLS CUI [4])
Central Nervous System Agents Patient need for | Antidepressive Agents | Mood Stabilizer | Anticonvulsants
Item
patients must not require concomitant treatment with any other medication with primarily central nervous system activity, including antidepressants, mood stabilizers, and anticonvulsants.
boolean
C0007680 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0003289 (UMLS CUI [2])
C2917435 (UMLS CUI [3])
C0003286 (UMLS CUI [4])
C0686904 (UMLS CUI [1,2])
C0003289 (UMLS CUI [2])
C2917435 (UMLS CUI [3])
C0003286 (UMLS CUI [4])
Substance Dependence | Nicotine Dependence | Caffeine dependence
Item
patients must not have a substance (except nicotine or caffeine) dependence within the past 30 days
boolean
C0038580 (UMLS CUI [1])
C0028043 (UMLS CUI [2])
C1386553 (UMLS CUI [3])
C0028043 (UMLS CUI [2])
C1386553 (UMLS CUI [3])